Kendle hired Jeffrey Zucker as senior director of patient recruitment. A psychologist, he previously worked at Merck, Lilly and CRI Worldwide. Here's a release. ClinTec International raised $12.4 million from Elephant Capital, a British investor group that is focusing on opportunities in India. The contract research organization will also get three new board members as part of…more...

What are appropriate turnaround times as images pass through the different stages of a clinical trial? Is the pharmaceutical industry applying outmoded thinking? Here's the context for such questions. A few weeks back, we ran an article on benchmarks in imaging. In brief, Perceptive Informatics, a division of Parexel, had adopted some standards in consultation with a…more...

Safety. Efficacy. Are those two cardinal notions of clinical development enough? Jean Paty has a third. He believes it is as central as safety and efficacy. Paty is co-founder and senior VP of scientific, quality and regulatory affairs at invivodata, a Pittsburgh, Penn., electronic patient diary firm. If safety and efficacy are the X and Y axes…more...

History records that after her husband was assassinated, someone asked Mrs. Abraham Lincoln about the theatrical production she had just seen. With all deference to Mrs. Lincoln, we are in a similarly stunned state of mind after talking to Kit Howard, principal of Kestrel Consultants. Based in Michigan, with a Canadian's calm demeanor, Howard speaks in methodical,…more...

With more than two decades in the industry under his belt, Jeffrey Trotter had his own contract research organization (CRO) for more than a decade. He sold it—twice. And now he's helping to shepherd the late-phase strategy at PharmaNet Development Group, where his title is executive VP, Phase IV development. He supervises a 50-person group dedicated to…more...

Last Friday, we wrote up the recent Drug Information Association (DIA) presentation by Quintiles VP of global data solutions, Thomas Grundstrom. But the ground rules of the DIA meeting bar speakers from self-promotion or advancing the messages of their employers. That left us with a few unanswered questions. Grundstrom was happy to address those in a conversation…more...

Almac launched a new program to help sponsors find biomarkers. Said Paul Harkin, president and managing director of the company's diagnostics division: “We have combined a range of key solutions which are ideally suited to growing biopharma companies.” PPD will expand its laboratory services on the east coast of the U.S. to handle cGMP projects for biotechnology…more...